Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, BridgeBio Pharma Inc’s stock clocked out at $32.59, up 0.77% from its previous closing price of $32.34. In other words, the price has increased by $0.77 from its previous closing price. On the day, 2.68 million shares were traded. BBIO stock price reached its highest trading level at $33.19 during the session, while it also had its lowest trading level at $32.39.
Ratios:
To gain a deeper understanding of BBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.67 and its Current Ratio is at 4.67.
On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Valantine Hannah sold 12,875 shares for $32.58 per share. The transaction valued at 419,500 led to the insider holds 1,764 shares of the business.
KKR Genetic Disorder L.P. sold 6,000,000 shares of BBIO for $197,760,000 on Mar 05 ’25. The 10% Owner now owns 19,260,971 shares after completing the transaction at $32.96 per share. On Mar 06 ’25, another insider, HANNAH A VALANTINE, who serves as the Director of the company, bought 12,875 shares for $32.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 6198259200 and an Enterprise Value of 7258022400. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.93. Its current Enterprise Value per Revenue stands at 32.708 whereas that against EBITDA is -13.082.
Stock Price History:
The Beta on a monthly basis for BBIO is 1.11, which has changed by 0.19159055 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, BBIO has reached a high of $39.47, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is -1.65%, while the 200-Day Moving Average is calculated to be 16.70%.
Shares Statistics:
It appears that BBIO traded 2.90M shares on average per day over the past three months and 3395000 shares per day over the past ten days. A total of 190.04M shares are outstanding, with a floating share count of 155.49M. Insiders hold about 18.25% of the company’s shares, while institutions hold 76.14% stake in the company. Shares short for BBIO as of 1740700800 were 22155112 with a Short Ratio of 7.64, compared to 1738281600 on 18776419. Therefore, it implies a Short% of Shares Outstanding of 22155112 and a Short% of Float of 17.819999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
